ODYY
Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | 0.01 | $0 | -$318,521 |
| 2026 Q2 | -0.03 | $0 | -$284,259 |
| 2025 Q1 | -0.00 | $0 | -$283,998 |
| 2025 Q4 | -0.00 | $0 | -$48,200 |
| 2025 Q3 | -0.00 | $0 | -$4,000 |
| 2025 Q2 | -0.00 | $0 | -$46,678 |
| 2024 Q1 | -0.01 | $0 | -$248,514 |
| 2024 Q4 | -0.13 | $3,076 | -$63,635 |